/

Avenzo Therapeutics

Developing next-generation oncology therapies for cancer patients.

BiotechnologyPharmaceuticals

avenzotx.com ↗

Company facts

Founded: 2022
Employees: 125
Headquarters: United States
Type: Private
Funding: Series B · $60M · 2025